Vertex Pharmaceuticals, Inc. (VRTX)
431.74
-2.56
(-0.59%)
USD |
NASDAQ |
Apr 07, 16:00
434.73
+2.99
(+0.69%)
After-Hours: 19:08
Vertex Pharmaceuticals EPS Diluted (Quarterly) : 4.651 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Amgen, Inc. | 2.455 |
| Moderna, Inc. | -2.107 |
| Eli Lilly & Co. | 7.024 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.191B |
| Revenue (Quarterly) | 3.227B |
| Total Expenses (Quarterly) | 2.036B |
| Enterprise Value | 105.75B |
| Gross Profit Margin (Quarterly) | 85.56% |
| Profit Margin (Quarterly) | 36.91% |
| Earnings Yield | 3.59% |
| Operating Earnings Yield | 4.30% |
| Normalized Earnings Yield | 3.924 |